Thermo Fisher Scientific Inc. Stock Bulgaria S.E.
Equities
TN8
US8835561023
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
549.4 EUR | +0.07% | +3.04% | +13.92% |
Sales 2024 * | 43.01B 39.76B 58.7B | Sales 2025 * | 46.08B 42.59B 62.89B | Capitalization | 225B 208B 308B |
---|---|---|---|---|---|
Net income 2024 * | 6.11B 5.65B 8.34B | Net income 2025 * | 7B 6.47B 9.55B | EV / Sales 2024 * | 5.8 x |
Net Debt 2024 * | 23.99B 22.18B 32.74B | Net Debt 2025 * | 19.18B 17.73B 26.18B | EV / Sales 2025 * | 5.31 x |
P/E ratio 2024 * |
37.3
x | P/E ratio 2025 * |
31.8
x | Employees | 122,000 |
Yield 2024 * |
0.25% | Yield 2025 * |
0.28% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific Inc.
1 day | +0.07% | ||
1 week | +3.04% | ||
Current month | +2.43% | ||
1 month | +2.38% | ||
3 months | +8.94% | ||
6 months | +32.65% | ||
Current year | +13.92% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
C. Harris
BRD | Director/Board Member | 67 | 12-03-29 |
Ruby Chandy
BRD | Director/Board Member | 62 | 22-02-28 |
Date | Price | Change |
---|---|---|
24-05-12 | 549 | +0.11% |
24-05-14 | 552 | +0.53% |
24-05-13 | 549 | +0.11% |
24-05-10 | 548.4 | +2.84% |
24-05-09 | 533.3 | -0.03% |
End-of-day quote Bulgaria S.E., May 12, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.07% | 186B | |
+13.88% | 135B | |
+27.12% | 107B | |
+0.91% | 63.56B | |
+6.74% | 51.32B | |
+13.39% | 51.04B | |
+8.81% | 43.3B | |
+4.14% | 36.99B | |
+25.48% | 32.01B |
- Stock Market
- Equities
- TMO Stock
- TN8 Stock